Zotefoams PLC Director/PDMR Shareholding (9289C)
October 22 2020 - 5:36AM
UK Regulatory
TIDMZTF
RNS Number : 9289C
Zotefoams PLC
22 October 2020
Zotefoams plc
(the 'Company')
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
On 20 October 2020, the Company received notice from its
Employee Benefit Trust of the exercise and partial sale for tax of
nil cost options granted over ordinary shares of 5 pence each
('Shares') under the Company's Deferred Bonus Share Plan ('DBSP')
by Mr J P Bridges as follows:
Total number of Number of shares Aggregated
shares sold sold for tax Sale price
(GBP)
10,934 5138 GBP4.29
----------------- ------------
Awards granted under the DBSP usually vest three years from
grant, subject to satisfaction of service conditions. However,
given the unprecedented circumstances brought about by COVID-19,
and the decision of the Board not to recommend a final dividend for
the year ended 31 December 2019, the proportion of the bonus that
would normally have been paid in cash was deferred into shares (the
'Deferred Bonus proportion'). The Remuneration Committee approved
the exercise of the Deferred Bonus proportion with effect from 20
October 2020 for non-Board PDMRs. The proportion of the bonus that
would normally be deferred into shares (25%) will continue as
normal and will be released after three years.
The award was increased to reflect the dividend paid during the
restricted period.
The Notification of Dealing Form can be found below.
This announcement is made in accordance with the requirements of
Article 19 of the EU Market Abuse Regulation 596/2014.
Lydia Harratt
Group Company Secretary
Zotefoams plc
020 8664 1600
22 October 2020
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular
materials technology delivering optimal material solutions for the
benefit of society. Utilising a variety of unique manufacturing
processes, including environmentally friendly nitrogen expansion
for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance
foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses
its own cellular materials to manufacture T-FIT(R) advanced
insulation for demanding industrial markets. Zotefoams also owns
and licenses patented microcellular foam technology to reduce
plastic use in extrusion applications and for ReZorce(R)
mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional
manufacturing sites in Kentucky and Oklahoma, USA (foam products
manufacture and conversion), Massachusetts, USA (MuCell Extrusion)
and Jiangsu Province, China (T-FIT(R)). A third foam-manufacturing
site, in Poland, is planned to begin operations in 2021.
www.zotefoams.com
AZOTE(R), ZOTEK(R), ReZorce(R) and T-FIT(R) are registered
trademarks of Zotefoams plc.
ZOTEFOAMS PLC
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND
THEIR CLOSELY ASSOCIATED PERSONS
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: James Peter Bridges
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Senior Executive
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Zotefoams plc
---------------------------------------------------------------------
b) LEI: 213800B6P256B5XN8D32
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary shares of 5 pence each
Identification code: GB0009896605
---------------------------------------------------------------------
b) Nature of the transaction: Exercise and sale of shares
under the Deferred Bonus Share Plan
---------------------------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
GBP4.291950 2,300
----------
GBP4.20 1,000
----------
GBP4.30 7,583
----------
GBP4.27 51
----------
---------------------------------------------------------------------
d) Aggregated information:
Aggregate Price Aggregate Volume Aggregate Total
GBP4.29 10,934 GBP46,906.86
----------------- ----------------
---------------------------------------------------------------------
e) Date of the transaction: 20 October 2020
---------------------------------------------------------------------
f) Place of the transaction: XLON
---------------------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEANEAADDEFEA
(END) Dow Jones Newswires
October 22, 2020 05:36 ET (09:36 GMT)
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Apr 2024 to May 2024
Zotefoams (LSE:ZTF)
Historical Stock Chart
From May 2023 to May 2024